Humbert-Vidan Laia, Kamel Serageldin, Wentzel Andrew, Kaffey Zaphanlene, Abdelaal Moamen, Spier Kyle B, West Natalie A, Marai G Elisabeta, Canahuate Guadalupe, Zhang Xinhua, Chen Melissa M, Wahid Kareem A, Rigert Jillian, Hosseinian Seyedmohammadhossein, Schaefer Andrew J, Brock Kristy K, Chambers Mark, Otun Adegbenga O, Aponte-Wesson Ruth, Patel Vinod, Hope Andrew, Phan Jack, Garden Adam S, Frank Steven J, Morrison William H, Spiotto Michael T, Rosenthal David, Lee Anna, He Renjie, Naser Mohamed A, Watson Erin, Hutcheson Katherine A, Mohamed Abdallah S R, Sandulache Vlad C, van Dijk Lisanne V, Moreno Amy C, Urbano Teresa Guerrero, Fuller Clifton D, Lai Stephen Y
The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
University of Illinois Chicago, Chicago, IL, USA.
Radiother Oncol. 2025 Jun;207:110890. doi: 10.1016/j.radonc.2025.110890. Epub 2025 Apr 11.
Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has important implications to monitor oral health in head and neck cancer (HNC) long-term survivors.
Data were retrospectively obtained for a clinical observational cohort of 1129 patients (198 ORNJ cases) with HNC treated with radiotherapy (RT) at The University of Texas MD Anderson Cancer Center. A Weibull Accelerated Failure Time model was trained on previously identified dosimetric, clinical and demographic predictors. External validation was performed using an independent cohort of 265 patients (92 ORNJ cases) treated at Guy's and St. Thomas' Hospitals. To facilitate clinical implementation of the model, an online graphical user interface (GUI) was developed, including formal stakeholder usability testing.
Our model identified that gender (males), pre-RT dental extractions and D25% were associated with a 38 %, 27 % and 12 % faster onset of ORNJ, respectively, with adjusted time ratios of 0.62 (p = 0.11), 0.73 (p = 0.13) and 0.88 (p < 0.005). The model demonstrated strong internal calibration (integrated Brier score of 0.133, D-calibration p-value 0.998) and optimal discrimination at 72 months (Harrell's C-index of 0.72).
This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose and patient-related factors not only on the probability of a late effect (ORNJ), but the conditional risk during survivorship.
现有的关于颌骨放射性骨坏死(ORNJ)的研究主要使用横断面数据,在单一时间点评估风险因素。确定ORNJ的事件发生时间特征对于监测头颈癌(HNC)长期幸存者的口腔健康具有重要意义。
回顾性获取了德克萨斯大学MD安德森癌症中心接受放射治疗(RT)的1129例HNC患者(198例ORNJ病例)的临床观察队列数据。在先前确定的剂量学、临床和人口统计学预测因素上训练了威布尔加速失效时间模型。使用盖伊和圣托马斯医院治疗的265例患者(92例ORNJ病例)的独立队列进行外部验证。为便于模型的临床应用,开发了一个在线图形用户界面(GUI),包括正式的利益相关者可用性测试。
我们的模型确定,性别(男性)、放疗前拔牙和D25%分别与ORNJ发病快38%、27%和12%相关,调整后的时间比分别为0.62(p = 0.11)、0.73(p = 0.13)和0.88(p < 0.005)。该模型显示出很强的内部校准(综合Brier评分为0.133,D校准p值为0.998),并在72个月时具有最佳辨别力(Harrell's C指数为0.72)。
本研究首次证明了放射剂量与ORNJ发病时间之间的直接关系,不仅提供了关于所给予剂量和患者相关因素对晚期效应(ORNJ)概率的影响的新特征,还提供了生存期间的条件风险。